NYSE Owner Challenges Hyperliquid with Regulated Oil Futures

Brent crude oil is trading at $104.06, down 2.8% from the previous close. The RSI is in weak territory at 44, while the MACD remains below the signal line and negative. A close below the 20- and 50-day moving averages confirms short-term pressure. News that NYSE is launching regulated oil futures to compete with Hyperliquid could ease supply concerns in the market. However, weak technical indicators and a bearish trend suggest that downward movement may continue in the near term.

WTI crude oil has lost more than 3% in the last 24 hours, falling to $97.64. The RSI is at 46, indicating weakening momentum, while the MACD remains in negative territory below the signal line. The price is trading below both the 20-day and 50-day moving averages, further weakening the short-term technical outlook. The news notes that NYSE's entry into the regulated oil futures market could bring competition to alternative platforms like Hyperliquid, but the direct impact on supply-demand balance may remain limited. The weakness in technical indicators and the recent downward trend suggest that bearish pressure could persist in the short term.

Exxon Mobil (XOM) shares fell 4.5% in the last 24 hours, closing at $154.35. While the RSI at 37 approaches oversold territory, the MACD line remains below the signal line and in negative territory, indicating continued short-term bearish momentum. The stock is trading below both its 20-day ($157.48) and 50-day ($156.68) moving averages, further weakening the technical outlook. The news relates to NYSE launching regulated oil futures to compete with Hyperliquid, which could slightly reduce demand for traditional oil stocks. However, the direct impact of this news is limited, with the current technical weakness taking precedence.

Chevron (CVX) shares closed 2.5% lower, with the RSI at 42.5, indicating weak momentum. The MACD line remains below the signal line and in negative territory, suggesting continued short-term weakness. The stock is trading below both its 20-day and 50-day moving averages, pointing to sustained selling pressure. While news of NYSE competing with Hyperliquid may be circulating, it is not a direct catalyst for CVX and is unlikely to impact broader market sentiment. The bearish trend is expected to persist in the near term, though a sharp rebound is unlikely as the stock has not yet entered oversold territory.